Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- pain -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (14)	8/19/2003 12:51:22 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 101

And it comes out of Tucson, home of epitan et al. Cool. There are millions of stoners out there, doing the experiments. As old hippies sober up, they learn about the diseases that they've had all those years. >> CB2 receptor-selective agonist medications are predicted to be without the CNS side effects that limit the effectiveness of currently available medications. << The discussion section could be hilarious. Stand up comics should get ahold of this stuff. Cheech and Chong on the History of Medical Research.